Hospital-Acquired Infection Control Market Analysis and Opportunity Assessment 2023 to 2033

According to Future Market Insights' newly released Hospital-acquired Infection Control Market analysis report, global sales of Hospital-acquired Infection Control in 2023 are expected to be US$ 6.5 billion. The market is expected to reach US$ 12.7 billion by 2033, with a CAGR of 7% from 2023 to 2033. Hospitals and Intensive Care Units are predicted to create considerable revenue in the market, with a CAGR of 7.6%.

The occurrence of hospital-acquired infections, the increasing proportion of surgical procedures, the growing geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.

The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, are projected to increase demand for hospital-acquired infection management.

Over the years, the percentage of surgeries performed worldwide has increased significantly. According to the WHO, roughly 235 million difficult surgical procedures are conducted worldwide each year. This is attributed to a rise in obesity and other lifestyle disorders, an increase in the senior population, and an increase in the incidence of spinal injuries and sports-related injuries.

As the number of surgical procedures performed increases, so does the demand for various surgical equipment and medical gadgets. The demonstrated benefits of sterilised product lines, as well as increased awareness of their efficacy in healthcare settings, are projected to stimulate demand for hospital-acquired infection services.

Because to increased demand for Hospital-acquired Infection Control methods in developing countries, particularly Japan, the Asia Pacific market is expected to grow at a CAGR of more than 7% during the forecast period.

The regional market is expanding as a result of the widespread use of hospital-acquired infection controls and greater working-class awareness of general health and fitness.

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Get More Details About Report@ https://www.futuremarketinsights.com/reports/hospital-acquired-infection-control-market

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis
By Component:

  • Equipment
  • Sterilization Equipment
  • Disinfection Equipment
  • Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others (Waste Disposal, PPE)
  • Services

By End-user:

  • Hospitals and Intensive Care Units
  • Ambulatory Surgical and Diagnostic Centers
  • Other End-users

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more